Lateral Flow Assay to detect CXCL10 as a diagnose-supporting biomarker for Polyomavirus-associated Nephropathy (PVAN) after kidney transplantation (KTx)
Open Access
- 27 August 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 26959
Abstract
Kidney grafts, as the most transplanted organs, require intensive monitoring to ensure optimal transplant survival rates for patients. These rates can be jeopardized by severe, difficult-to-treat opportunistic infections such as polyomavirus, which can lead to polyomavirus-associated nephropathy (PVAN). There is an urgent need for non-invasive biomarker tests to narrow down the number of patients who require a transplant biopsy to confirm PVAN. The chemokine CXCL10 was significantly elevated in urine samples from kidney transplant recipients (KTR) with biopsy-confirmed PVAN compared to KTRs with a protocol biopsy found to be normal (114.8 ± 177.3 pg/ml, n = 22 vs. 11.4 ± 22.3 pg/ml, p < 0.0001, n = 45). Therefore, we developed a lateral flow assay (LFA) for the detection of PVAN with an area under the curve (AUC) of 0.832 according to receiver operating characteristic analysis as a point-of-care test.Keywords
Funding Information
- Gottfried Wilhelm Leibniz Universität Hannover
This publication has 40 references indexed in Scilit:
- Transforming kidney transplant monitoring with urine CXCL9 and CXCL10: practical clinical implementationScientific Reports, 2024
- Histology versus molecular surveillance: claims and evidenceKidney International, 2023
- Normalizing the Optical Signal Enables Robust Assays with Lateral Flow BiosensorsACS Omega, 2022
- A new lateral flow assay to detect sIL-2R during T-cell mediated rejection after kidney transplantationThe Analyst, 2021
- Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantationClinical Immunology, 2021
- Lateral flow biosensors based on the use of micro- and nanomaterials: a review on recent developmentsMicrochimica Acta, 2019
- Lateral and Vertical Flow Assays for Point‐of‐Care DiagnosticsAdvanced Healthcare Materials, 2019
- A smartphone readout system for gold nanoparticle-based lateral flow assays: application to monitoring of digoxigeninMicrochimica Acta, 2019
- Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunityCytokine, 2018
- Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord BloodMolecular Therapy - Methods & Clinical Development, 2017